Clinical trials
Completed Phase 1/2 Coronavirus Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 18 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alkarkh Health Directorate-Baghdad | 1 |
| Apellis Pharmaceuticals, Inc. | 1 |
| Arcturus Therapeutics, Inc. | 1 |
| BioNTech SE | 1 |
| Camillo Ricordi | 1 |
| Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 1 |
| Clear Creek Bio, Inc. | 1 |
| Erasme University Hospital | 1 |
| Federal University of Minas Gerais | 1 |
| GeneOne Life Science, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronavirus Infections | 26 |
| COVID-19 | 21 |
| Respiratory Distress Syndrome | 4 |
| Virus Diseases | 4 |
| Pneumonia | 3 |
| Severe Acute Respiratory Syndrome | 3 |
| Pneumonia, Viral | 2 |
| Respiratory Tract Infections | 2 |
| Acute Lung Injury | 1 |
| Communicable Diseases | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.